Literature DB >> 16834733

Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.

A Girolami1, E Ruzzon, F Tezza, R Scandellari, S Vettore, B Girolami.   

Abstract

A thorough review of the literature and of personal files has allowed the gathering of 81 patients with rare congenital bleeding disorders and thrombotic phenomena. Sixteen of these patients had congenital afibrinogenemia, eight involved factor V deficiency, 20 factor VII defects, 33 factor XI deficiencies and only one, a factor XIII defect. Altogether 42 patients showed arterial thrombosis (myocardial infarction [MI] in 28 cases; ischemic stroke in 4; arterial occlusion in 8; 2 patients with disseminated intravascular coagulation (DIC)). Ages varied between 13 and 74. Twenty-two patients were males and 16 females. In four cases, sex was not reported. There were three fatalities: two after a MI and one because of heart failure. With regard to venous thrombosis: 9 patients had pulmonary embolism, 15 patients had deep vein thrombosis, 9 patients had both pulmonary embolism and deep vein thrombosis; 1 patient had superficial vein thrombosis, whereas, 5 cases had an unusual site venous thrombosis (two portal systems, two cerebral sinuses, one inferior vena cava) for a total of 39 cases. Age varied between 3 and 86. In this case, 20 patients were males and 17 were females. In two cases, sex was not reported. There were three fatalities: two because of pulmonary embolism and one because of inferior vena cava thrombosis. The fact that thrombosis has never been described in patients with factor II or factor X seems to underscore the central antithrombotic role that these two factors have in the coagulation system.

Entities:  

Mesh:

Year:  2006        PMID: 16834733     DOI: 10.1111/j.1365-2516.2006.01299.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  15 in total

Review 1.  Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

2.  Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome.

Authors:  Antonio Girolami; Silvia Vettore; Fabrizio Vianello; Giulia Berti de Marinis; Fabrizio Fabris
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

Review 3.  Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal.

Authors:  Larry R Jackson; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

4.  A clinical approach to inherited premature coronary artery disease.

Authors:  Nathan O Stitziel; Calum A MacRae
Journal:  Circ Cardiovasc Genet       Date:  2014-08

5.  Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation.

Authors:  A Girolami; N Candeo; G Berti De Marinis; E Bonamigo; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

6.  Treating a Patient of Dysfibrinogenemia with Acute Thromboembolism by Rivaroxaban and Cilostazol.

Authors:  Emre Ozker; Figen Atalay; Oyku Gulmez; Bulent Saritas
Journal:  Indian J Hematol Blood Transfus       Date:  2016-11-21       Impact factor: 0.900

7.  Thromboembolic events in patients with severe inherited fibrinogen deficiency.

Authors:  Amihai Rottenstreich; Avigal Lask; Lilliana Schliamser; Ariella Zivelin; Uri Seligsohn; Yosef Kalish
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 8.  Congenital FVII deficiency and thrombotic events after replacement therapy.

Authors:  Antonio Girolami; Irene Bertozzi; Ignazio Rigoni; Rodolfo Muzzolon; Silvia Vettore
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

9.  Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes).

Authors:  Antonio Girolami; Girolami Antonio; Silvia Vettore; Vettore Silvia; Emanuela Bonamigo; Bonamigo Emanuela; Fabrizio Fabris; Fabris Fabrizio
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

Review 10.  Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.

Authors:  A Girolami; F Tezza; R Scandellari; S Vettore; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.